Menu Close

Trending

LEO Pharma’s Adtralza approved by MHRA, EC for adolescent atopic dermatitis
New HHS rule would harmonise substance abuse privacy rule, HIPAA
Owkin taps Linux Foundation to open-source its AI learning software
AstraZeneca, C4XD sign exclusive $402 million global licence
Exploring a united vision for British pharma at Anthropy – the pharmaphorum podcast

agile

The enduring innovation and behaviour changes from COVID-19

Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

The enduring innovation and behaviour changes from COVID-19

, , , , , , , , , 0 Comment

The COVID-19 crisis has accelerated the shift to a more resilient, agile and innovative digitally-enabled world within healthcare

X
The enduring innovation and behaviour changes from COVID-19
https://pharmaphorum.com/views-analysis-digital/the-enduring-innovation-and-behaviour-changes-from-covid-19/
49597020648_93fee80c1b_c

News/ News/ R&D

UK trial begins testing second-wave COVID-19 drug from US biotech Ridgeback

, , , , 0 Comment

The AGILE programme, which is researching a second wave of COVID-19 therapies in the UK, has begun testing its first potential

X
UK trial begins testing second-wave COVID-19 drug from US biotech Ridgeback
https://pharmaphorum.com/news/uk-trial-begins-testing-second-wave-covid-19-drug-from-us-biotech-ridgeback/

Login

CONTINUE TO SITE >
X
Close in 10 seconds